enasidenib 100 MG Oral Tablet [Idhifa]

RxCUI: 1940372
RxNorm name: enasidenib 100 MG Oral Tablet [Idhifa]
Display name: enasidenib 100 MG Oral Tablet [Idhifa]
Full name: enasidenib 100 MG Oral Tablet [Idhifa]
Term type: SBD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:12

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Idhifa	ENASIDENIB MESYLATE	Celgene Corporation	a5b4cdf0-3fa8-4c6c-80f6-8d8a00e3a5b6	2025-01-16	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 1940372

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
a5b4cdf0-3fa8-4c6c-80f6-8d8a00e3a5b6	IDHIFA 100 MG Oral Tablet [PSN] · enasidenib 100 MG Oral Tablet [Idhifa] [SBD] · Idhifa 100 MG (as enasidenib mesylate 120 MG) Oral Tablet [SY]	3	12	These highlights do not include all the information needed to use IDHIFA safely and effectively. See full prescribing information for IDHIFA. IDHIFA ® (enasidenib) tablets, for oral use Initial U.S. Approval: 2017	20250116